The primary goal of this study is to determine the highest dose of ABM-1310 a person can take while benefiting from treatment with ABM-1310 when taken by mouth by adult patients with BRAF V600 mutated advanced solid tumors (tumors that have either spread or are no longer responding to treatment), which have progressed despite receiving the standard treatment or whose cancer does not have a standard treatment. BRAF is a gene that encodes a protein also called BRAF. This protein plays a role in cell growth by sending signals inside the cell promoting cell division. The study will have three...
